lasik surgeons


USAEyes is a nonprofit Lasik patient advocacy organization
USAEyes Lasik grant application.
How to Pick
A Lasik Doctor
۰ Certified Lasik Doctor
۰ Why Choose USAEyes
Certified Lasik Doctors
۰ 50 Tough Questions For
  Your Lasik Doctor
Ask Lasik Expert
۰ Lasik Q&A Forum
Top Articles
۰ Lasik Results
۰ All About Lasik
۰ Lasik Cost
۰ Wavefront Custom Lasik
۰ Lasik Patient Survey
Lasik Alternative
Top Articles
۰ Monovision Lasik
۰ PRK, LASEK, Epi-Lasik
۰ RLE Lens Exchange

Digg,, Reddit, Bookmark, etc. this page.

Add Lasik page to Digg,, Reddit, My Favorites, Facebook, Ask, and others.


Lasik Doctors


New Bladeless Lasik for US

Zeiss receives FDA approval for femtosecond laser to be used for Bladeless Lasik.

Bladeless Lasik


Jan 18, 2007 DUBLIN, CA MARKET WIRE -- Carl Zeiss Meditec, Inc. (CZM) reported that it has received U.S. Food & Drug Administration (FDA) clearance to market the laser keratome applications of its VISUMAX femtosecond laser system. The company had previously projected that this clearance would be granted in the second half of 2007, and the more rapid achievement of this process is an important and welcomed milestone for the company.

The VISUMAX system is designed to provide smooth and precise flap cutting capabilities for refractive laser surgery. This technology, combined with CZM's MEL 80 excimer laser, delivers excellent clinical outcomes coupled with the potential for a unique optimized work flow for refractive surgeons and improved comfort for their patients. Using a unique pivoting patient bed and an integrated data management system, the refractive surgeon will be able to complete a full refractive procedure without the need to move the patient or to perform redundant data entries. Alternatively, either platform may be used separately and/or in conjunction with other laser systems, but without the full system integration benefits.

Both MEL 80 and VISUMAX technologies were recently displayed and demonstrated at the American Academy of Ophthalmology (AAO) in Las Vegas. The MEL 80 is an advanced refractive laser system that has been marketed outside the U.S. since 2002. The MEL 80 recently gained FDA clearance for sale in the U.S., and the related clinical trials showed that 93 percent of patients were corrected to 20/20 or better visual acuity, with 41 percent achieving 20/12.5 or better at six months. With the subsequent FDA clearance of the VISUMAX femtosecond platform, the company is now positioned to more fully exploit the technology advantages and clinical benefits of its full refractive laser portfolio.

A commercial launch of the femtosecond technology is planned for mid-2007. In the interim, the company will continue ongoing clinical evaluations for the recently approved laser keratome applications. The company has also recently demonstrated the unique potential of the VISUMAX technology to perform a complete "all in one" refractive correction procedure, and clinical testing will be continued for that application as well.

"We believe that the field of refractive laser surgery offers significant opportunity for the type of technology innovation that Zeiss has pursued throughout our 160 year history," said Jim Taylor, president and CEO of Carl Zeiss Meditec, Inc. "Since our initial disclosure of the clinical progress of our femtosecond system, we have been gratified by the enthusiastic encouragement and support that we have received from experienced refractive surgeons around the world. They recognize the inherent potentials in these advances along with the significant benefits that will emerge for patients and for clinicians who expect and require the most advanced refractive correction technologies and techniques."

"The apparent advantages of the VISUMAX system are not limited to those normally recognized for a femtosecond laser flap cut," stated Walter Sekundo, MD, of the University of Mainz, Germany. "Due to the special design of the contact glass and the low IOP increase, the perfusion of the central retinal artery has not been impaired, and our patients were able to see the fixation light throughout the procedure. Moreover, the VISUMAX provides a new level of cutting accuracy for corneal incisions, as evidenced by the results of our successful demonstration of the so-called Femtosecond Lenticule Extraction procedures."

"In my opinion," Sekundo continued, "these features contributed significantly to our excellent visual acuity results of up to 20/10 one day post-op, and we saw no incidence of transient light sensitivity syndrome (TLSS) or DLK in any of the study group patients."

Tags: , , , , ,

"Consider and Choose With Confidence" TM

A few of the communities where Lasik doctors are certified by USAEyes :

Materials presented in this website are for informational purposes only and are not medical advice. See full Terms of Use.
Unless otherwise indicated, Copyright 1997-2012 © Council for Refractive Surgery Quality Assurance, a nonprofit organization.
800/USA-Eyes - 800/872-3937
No images, graphics, or text may be reproduced in any media without express written permission.
USAEyes, CRSQA, Council for Refractive Surgery Quality Assurance,
50 Tough Questions For Your Lasik Doctor, and Consider and Choose With Confidence are trademarks of the
Council for Refractive Surgery Quality Assurance
All Rights Reserved.